GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (OTCPK:LOVFF) » Definitions » Total Stockholders Equity

LOVFF (Cannara Biotech) Total Stockholders Equity : $65.87 Mil (As of Feb. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Total Stockholders Equity?

Cannara Biotech's Total Stockholders Equity for the quarter that ended in Feb. 2025 was $65.87 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cannara Biotech's Book Value per Share for the quarter that ended in Feb. 2025 was $0.72. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cannara Biotech's Debt-to-Equity for the quarter that ended in Feb. 2025 was 0.52.


Cannara Biotech Total Stockholders Equity Historical Data

The historical data trend for Cannara Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Total Stockholders Equity Chart

Cannara Biotech Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Total Stockholders Equity
Get a 7-Day Free Trial 29.00 50.89 51.67 59.17 64.41

Cannara Biotech Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.77 59.83 64.41 64.82 65.87

Cannara Biotech  (OTCPK:LOVFF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cannara Biotech's Book Value per Share for the quarter that ended in Feb. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cannara Biotech's Debt-to-Equity for the quarter that ended in Feb. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannara Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannara Biotech Business Description

Traded in Other Exchanges
Address
1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .